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Abstract
Background: Histone deacetylases (HDACs) play a major role in the regulation of gene
transcription, often leading to transcriptional repression, as well as other effects following
deacetylation of non-histone proteins.
Results: To investigate the role of HDACs in the developing mammalian retina, a general inhibitor
of HDACs, trichostatin-A (TSA), was used to treat newborn murine retinae in explant cultures.
Inhibition of HDAC activity resulted in a reduction in RNA levels for genes that regulate retinal
development, as well as cell cycle regulators. Several of the genes encode transcription factors
essential for rod photoreceptor development, Otx2, Nrl, and Crx. Using luciferase reporter assays,
the promoter activity of both Nrl and Crx was found to be compromised by HDAC inhibition.
Furthermore, downregulation of gene expression by HDAC inhibition didn't require de novo
protein synthesis, and was associated with hyperacetylation of histones and non-histone proteins.
Finally, HDAC inhibition in retinal explant cultures resulted in increased cell death, reduction in
proliferation, a complete loss of rod photoreceptors and Müller glial cells, and an increase in bipolar
cells.
Conclusion: HDAC activity is required for the expression of critical pro-rod transcription factors
and the development of rod photoreceptor cells.
Background
Histone acetylation is a posttranslational modification
that leads to changes in chromatin structure and transcrip-
tion. The acetylation level of histones is governed by the
opposing effects of two enzymes, histone acetyltrans-
ferases (HATs) and histone deacetylases (HDACs), which
are responsible for adding and removing acetyl groups
from lysine residues, respectively. It is generally believed
that HDACs lead to transcription repression as histone
hypoacetylation results in a tightly packaged chromatin
structure, denying accessibility to transcription regulatory
proteins. Histone hyperacetylation relaxes chromatin
structure and is associated with increased transcriptional
acitivity [1-4]. However, histones are not the sole target of
HDACs. Other non-histone HDAC substrates include
transcription factors, such as E2F1, MyoD, GATA-1, and
p53 [5-9], as well as proteins in the cytoplasm, such as
tubulin and hsp90 [10-14].
Mammalian HDACs can be classified into two groups
based upon their structure and sequence homology to
their yeast counterparts. Class I HDACs (HDAC 1, 2, 3, 8)
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expressed in all tissues. The subcellular localization of
Class I HDACs is almost exclusively in the nucleus. Class
II HDACs (HDAC 4, 5, 6, 7, 9, 10) consist of a C-terminal
catalytic domain and an N-terminal portion that is used to
mediate interactions with other proteins. Class II HDACs
are preferentially expressed in cardiac muscle, skeletal
muscle, and brain. Interaction of Class II HDACs with
MEF2 silences the expression of MEF2 target genes, thus
suppressing myocyte differentiation [15-17]. Phosphor-
ylation of Class II HDACs by CaMK and other kinases
causes their shuttling out of the nucleus and accumula-
tion in the cytoplasm, thus releasing their suppression of
MEF2 target genes [18,19]. Although substantial evidence
is available that HDACs play a role in transcription repres-
sion, recent findings clearly demonstrate that HDACs can
act as transcription activators as well. SRC promoter
repression by HDAC inhibition is one example [20];
blockade of cytokine-inducible gene expression and anti-
viral immune response by the loss of HDAC activity is
another [21-24].
The retina is a highly-organized tissue specialized for sens-
ing light and processing the signal that originates from
activated photoreceptors. The mature retina is composed
of 6 neuronal and 1 glial cell type. Each of the different
cell types is generated in a specific time window from
multipotent retinal progenitor cells. The cell fate decision
made by a retinal cell depends upon both the intrinsic
properties of its progenitor as well as environmental cues
[25,26]. We have proposed that progenitor cells go
through a progression of competency states, each defined
by the ability to make different retinal cell types [25]. Each
competency state is likely controlled by a distinct network
of transcription factors. For example, a specific set of tran-
scription factors may allow a multipotent progenitor cell
to respond to a particular extrinsic cue to produce a rod
photoreceptor. Rod photoreceptor cells are the most
abundant cell type in the rodent retina; they are almost
continually produced from retinal progenitor cells during
the embryonic and neonatal period, overlapping the pro-
duction of almost all the other cell types. A terminally dif-
ferentiated rod photoreceptor cell can be identified by the
expression of the visual pigment protein, Rhodopsin. We
and others have identified Otx2, Nrl, and Crx, as critical
transcription factors required for rod photoreceptor devel-
opment [27-32]. Moreover, Nrl and Crx physically inter-
act with each other to activate the Rhodopsin promoter
[33]. However, the mechanisms controlling the expres-
sion of these transcription factors remain largely
unknown.
To probe a potential role of HDACs in the regulation of
retinal gene expression, we applied TSA, a potent drug that
inhibits all HDACs, to retinal explant cultures and assayed
gene expression changes. HDAC inhibition led to a
marked reduction in gene expression for all three (Otx2,
Nrl, Crx) transcription factors required for rod photore-
ceptor development. By microarray analysis, the effect of
HDAC inhibition on gene expression was observed to be
mainly restricted to a specific subset of genes essential for
retinal development, rather than a global alteration in a
large number of genes. These data suggest a net positive
effect of HDACs on retinal gene expression. Downregula-
tion of gene expression by TSA took place within 3 hours,
and the TSA effect didn't require new protein synthesis.
Furthermore, a promoter-reporter analysis showed that
HDAC activity is a positive regulator of the promoter
activity of Nrl and Crx. Interestingly, HDAC inhibition in
retinal explant cultures blocked rod photoreceptor and
Müller glial development, while increasing the number of
bipolar cells, suggesting a role for HDACs in cell fate deci-
sions.
Results
HDAC activity is required for the expression of critical 
genes for rod photoreceptor development
To determine if HDACs might play a role in retinal devel-
opment, RT-PCR was used to examine the expression of
members of Class I (HDAC1 and 3) and Class II HDACs
(HDAC4, 5, and 6) in the developing mouse retina. RNA
samples were analyzed at postnatal day 2 (P2), when rod
photoreceptor, bipolar and Müller glial cells are produced
[34]. Full-length coding regions of HDAC1 and HDAC3,
as well as ~200 bp from the 3' regions of HDAC4, 5, and
6, were amplified. The identity of amplified cDNAs was
confirmed by DNA sequencing. The results indicate that
HDAC1 and 3 (Class I) and HDAC4, 5, and 6 (Class II
HDACs) are expressed in the developing murine retina
(data not shown).
Rod photoreceptors constitute the major cell type in the
murine retina [34]. Proper differentiation of rods requires
the action of the transcription factors, Otx2, Nrl, and Crx.
Compromise of any of these factors results in a total loss
of, or severely compromised, rod photoreceptor develop-
ment. To probe the role of HDACs in the development of
rod photoreceptors, TSA, a potent inhibitor of both Class
I and Class II HDACs, was used to treat P2 mouse retinal
explant cultures. After 3 hours of TSA treatment, a signifi-
cant reduction was seen in the levels of RNA for Otx2, Nrl,
and Crx, while the expression of a house keeping gene,
GAPDH, remained unchanged (Fig. 1). A similar level of
downregulation was observed for these three genes using
two other HDAC inhibitors, valproic acid (VPA) and
sodium bytyrate (NaB), for a 3-hour treatment in P2
mouse explant cultures (data not shown).Page 2 of 12
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subset of genes
To investigate whether the inhibition of HDACs caused a
global change in gene expression, or whether the effect
was restricted to a subset of genes, a cDNA microarray
assay was performed comparing expression profiles of
TSA treated and vehicle DMSO treated samples. Three
hours after the drug treatment, total RNA was extracted
from P2 mouse retinae. TSA treated samples were labeled
by cy3, DMSO treated samples were labeled by cy5.
Labeled cDNAs were hybridized to a cDNA chip (Experi-
mental Procedures) and plotted with a log ratio (Fig. 2A).
A dye swap experiment also was performed in which each
probe was labeled with the other dye. Widespread gene
expression changes were not observed; changes were
restricted to a subset of genes. Among those downregu-
lated (points distributed above the 45° degree diagonal)
by TSA, were Otx2 and Crx, as originally identified by the
candidate approach shown in Fig. 1. TSA downregulated
genes (Fig. 2B) can be divided into two groups. Group 1
consists of retinal development regulators, including
Otx2, Crx, Neurod1, and Neurod4/Math3. Neurod1 and
Neuod4/Math3 are two other transcription factors that
positively regulate neuron development, including rod
photoreceptor development [35-37]. Group 2 consists of
cell cycle regulators, including CyclinD1, Cdk4, and
Cdk2. The downregulation of cell cycle regulators is con-
sistent with the known anti-proliferation effect observed
following inhibition of HDAC activity [38,39]. Recent
studies showed that HDAC1 mutants manifested defects
in the retinal cell proliferation and cell-cycle exit in
zebrafish([40,41]. Among TSA-upregulated genes (points
distributed below the 45° diagonal), was a gene encoding
a synaptosomal-associated protein, SNAP25 (Fig. 2C),
suggesting HDACs may also play a role in synaptogenesis.
Through the microarray analysis, it seems that HDAC
activity is required for regulation of a subset of genes
expressed during retinal development.
HDAC activity is required for maintaining the expression 
of pro-rod genes
The group of genes specifically downregulated by HDAC
inhibition that have known functions for retinal develop-
ment were studied further. To validate the microarray
results, P2 mouse retinal explants were cultured in the
presence or absence of TSA, followed by Northern blot
analysis to monitor the time course of change in gene
expression for Otx2, Nrl, Crx, Neurod1 and Neurod4/
Math3. Downregulation of gene expression began to be
seen within 1.5 hours after TSA treatment. The effect was
obvious after 3 hours, and maintained at later time points
(Fig. 3A). The expression of TUG1, a putative non-coding
RNA involved in photoreceptor differentiation [42], was
not affected by TSA, nor was the expression of GAPDH
(Fig. 3A). Since the TSA effect was rather robust for the
developing retina, it was of interest to determine whether
HDAC activity is required for the maintained expression
of these genes in a mature retina. Nrl and Crx expression
levels in P21 mouse retinae, when retinal differentiation
is complete, were analyzed. Nrl and Crx were selected for
further analysis not only because they promote rod pho-
toreceptor formation, but they act together to transacti-
vate the promoter of the rhodopsin gene [33], a
functional marker for rod photoreceptor cells. P21 mouse
retinal explants were cultured in the presence of or
absence of TSA for 24 hours. Using Northern blot analysis,
it was found that the expression of Nrl was reduced to a
minimum level, and only a trace amount of Crx mRNA
remained (Fig. 3B), following TSA treatment.
HDACs positively regulate the promoter activity of Nrl and 
Crx
To investigate the mechanism through which the expres-
sion of rhodopsin activators is downregulated by HDAC
inhibition, the promoter activity of Nrl and Crx was exam-
ined upon HDAC inhibition using a luciferase reporter
assay. A 7 kb and 5 kb upstream regulatory sequence was
isolated for Nrl and Crx, respectively. Nrl and Crx
sequences were cloned into the pGL3-basic firefly luci-
ferase vector (Promega). Luciferase reporters were trans-
fected into P2 mouse retinal explants by in vitro
electroporation. A pCAG-renilla luciferase expression vec-
tor was co-electroporated to allow for normalization of
the transfection efficiency. Electroporated retinae were
allowed to recover overnight in culture. TSA was added for
Northern blot analysis of the expression of Otx2, Nrl, and Crx whe  P2 mouse retinal xplants were treated with 1 μM TSA or DMSO for 3 hoursFigur 1
Northern blot analysis of the expression of Otx2, Nrl, and 
Crx when P2 mouse retinal explants were treated with 1 μM 
TSA or DMSO for 3 hours.Page 3 of 12
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Effects of HDAC inhibition on retinal gene expressionFigure 2
Effects of HDAC inhibition on retinal gene expression. P2 mouse explant cultures were treated with 1 μM TSA or DMSO vehi-
cle control for 3 hours. Total RNA was extracted and labeled with cy3 or cy5 for TSA and DMSO treatments, respectively. 
cDNA microarray analysis is shown by a scatter plot in (A). TSA-downregulated genes are distributed above the 45° diagonal; 
and TSA-upregulated genes are distributed below it. TSA-downregulated genes listed in (B) encompass photoreceptor genes 
(Otx2 and Crx) and proneural genes (NeuroD1 and Math3/NeuroD4) as well as cell cycle regulators (CyclinD1, Cdk4, and 
Cdk2). TSA-upregulated genes shown in (C) include a synaptosomal-associated protein, SNAP25. Values given (B and C) rep-
resent the fold change upon TSA treatment. The second value (cy5/cy3) shows the fold change in a dye swap experiment.
BMC Developmental Biology 2007, 7:78 http://www.biomedcentral.com/1471-213X/7/78a 24 hour treatment before retinal lysates were subjected
to a dual luciferase assay. Shown in Fig. 4, the promoter
activity of Nrl in TSA-treated retinae was reduced to 11.5
± 3.3% of the normalized control with DMSO treatment
(n = 3). The promoter activity of Crx in TSA-treated retinae
was reduced to 23.5 ± 10.5% of the normalized control
with DMSO treatment (n = 3).
The effect of HDAC inhibiton on gene expression doesn't 
require de novo protein synthesis and is associated with 
hyperacetylation of multiple cellular proteins
To further understand HDAC regulation of gene expres-
sion, the question of whether the synthesis of new pro-
tein(s) was necessary for the inhibition of gene expression
by TSA was examined. To address this question, TSA was
co-applied to mouse retinal explant cultures with a pro-
tein synthesis inhibitor, cycloheximide, for 3 hours. The
expression of Nrl and Crx was assayed on Northern blots.
Co-treatment with cycloheximide did not change the
effect exerted by TSA. The expression of both Nrl and Crx
was almost undetectable when TSA and cycloheximide
were co-applied, whereas retinae treated with cyclohex-
imide alone showed unaltered expression levels for Nrl
and Crx (Fig. 5A), compared to untreated controls. Appar-
ently, de novo protein synthesis was not required for the
downregulation of Nrl and Crx expression by HDAC inhi-
bition.
To identify HDAC target proteins which may be mediat-
ing the TSA effect, a pan-acetyl-lysine antibody was used
to examine acetylated proteins in western blots when P2
mouse retinae were treated by TSA for various time points.
As expected, a slightly increased histone acetylation was
seen 3 hours after TSA treatment, and a pronounced his-
tone acetylation was seen after 24 hours (Fig. 5B). In con-
trast to the slow kinetics of histone acetylation, robust
acetylation was seen only 3 hours after TSA treatment for
multiple non-histone targets, including α-tubulin with
the molecular weight about 50 kD, which is a substrate for
HDAC6, and two other proteins with molecular weights
close to 115 kD (Fig. 5C). The fast hyperacetylation of
these non-histone proteins coincided with the quick dis-
appearance of the levels of RNA for some retinal genes by
TSA, which became apparent in 3 hours.
HDAC inhibition affects development of several retinal cell 
types
Six neuronal and one glial cell type are produced from ret-
inal progenitor cells, with 4 cell types born in the neonatal
period in mice: rod photoreceptor cells, bipolar cells,
amacrine, and Müller glial cells. Since the expression of
critical genes for rod photoreceptor development was
dependent on the activity of HDACs, the effects of TSA on
rod development was assayed in an intact organ culture
system. P2 mouse retinal explants were cultured in the
(A) Northern blot analysis of the time course of changes in retinal gene expression when HDAC activity was inhibited in P2 mouse etinal explantsFig re 3
(A) Northern blot analysis of the time course of changes in retinal gene expression when HDAC activity was inhibited in P2 
mouse retinal explants. (B) Effect of HDAC inhibition on Nrl and Crx expression in P21 mouse retinal explants by Northern 
blot analysis.Page 5 of 12
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Retinal explants were then dissociated and subjected to
immunostaining with various cell type-specific antibod-
ies.
It was observed that after 8 days in culture, the total
number of cells from the TSA treated retinal explants was
reduced by 32.2 ± 5.2% (n = 3) compared to the DMSO-
treated controls, assessed by counting the number of dis-
sociated cells. The reduced cell number may reflect the
effect of HDAC inhibition on cell proliferation and/or cell
death. To distinguish between these possibilities, P2
mouse retinal explants were cultured in the presence or
absence of TSA for 20 hours before cell cycle progression
and cell death were assayed by BrdU labeling of mitotic
cells and TUNEL labeling of apoptotic cells, respectively.
Consistent with the finding that TSA treatment downreg-
ulates cell cycle regulators in the microarray analysis (Fig.
2), HDAC inhibition was found to cause a complete cell
cycle arrest; no BrdU positive cell was detected in the TSA
treated retinal explants compared to the controls (Fig.
6A). At the same time, while the DMSO-treated retinal
explants displayed minimal cell death in the ganglion cell
layer, many more apoptotic cells were found to be distrib-
uted across the retina (Fig. 6B) when HDAC activity was
inhibited by TSA. Therefore, the decreased total cell
number by TSA treatment was accounted for by the com-
bined effects of HDAC inhibition that led to both cell
cycle arrest and increased cell apoptosis. However, the
remaining TSA-treated cells looked morphologically nor-
mal when they were dissociated after 8 days in culture.
To assay the effects of TSA on retinal cell types, cultured
cells were dissociated and stained with several cell type-
specific antibodies. The immunostaining results were
quantified (Fig. 7) by counting marker positive cells from
3 independent experiments, with 800–1000 cells counted
for each marker in each experiment. For DMSO treated
retinal explants, ≈ 30.4 ± 7.4% cells were clearly Rho-
dopsin positive at P10. However, not even a single Rho-
dopsin positive cell was detected in TSA treated cultures.
To detect bipolar cells, an antiserum to Chx10, which is
expressed in bipolar and progenitor cells, was used. The
percentage of Chx10 positive cells in TSA treated samples
was increased by about 3 fold to 10.4 ± 3.5% from 3.5 ±
1.1% in controls. To check if different types of bipolar
cells were increased, dissociated cells were also stained for
PKCα, a marker of rod bipolar cells. In line with an
increase in Chx10 staining, there was a significant increase
in the percentage of PKCα positive cells when retinal
explants were cultured in the presence of TSA, 6.2 ± 1.2%
compared to 2.0 ± 0.8% in controls. The inhibition of
HDACs was also found to suppress the expression of
glutamine synthetase, a marker for Müller glial cells. Inhi-
bition of Müller glial development by TSA was confirmed
with antisera to two other Müller genes, CyclinD3 and
ApoE (data not shown). To check for changes in progeni-
tor cells, and/or cell types born prenatally, antisera to
Pax6, which labels progenitor cells, amacrine cells, gan-
glion cells, and horizontal cells, was used. There was no
significant difference in the number of Pax-6 expressing
cells in the TSA-treated retinas (13.6 ± 2.5%) versus con-
trols (10.76 ± 2.0%).
Discussion
Retinal progenitor cells are multipotent throughout devel-
opment, producing cell types in a conserved order. Early
progenitor cells give rise to early born cell types: the gan-
glion cells, horizontal cells, cones and amacrine cells. Late
progenitor cells produce late born cell types: the bipolar
cells and Müller glial cells. Rod photoreceptors, the major
cell type in the murine retina, are generated both before
and after birth, with peak production taking place around
birth [43]. This process is likely controlled by a network of
transcription factors that must be expressed at a particular
time and in specific cells. For instance, rod photoreceptor
development requires activation of Otx2, followed by the
expression of Nrl and Crx. Loss of Otx2 or Nrl leads to loss
of rod photoreceptor cells, while loss of Crx leads to a fail-
ure in differentiation of rod and cone photoreceptor cells
Luciferase reporter analysis of Nrl and Crx promoters in P2 mouse retinal explants (n = 3)Fig re 4
Luciferase reporter analysis of Nrl and Crx promoters in P2 
mouse retinal explants (n = 3). Firefly luciferase reporter 
constructs driven by Nrl or Crx promoter were electropo-
rated into retinal explants. Co-electroporation of a renilla 
luciferase reporter construct driven by a ubiquitous CAG 
promoter was used to normalize differences in the transfec-
tion efficiency. TSA-treated reporter activity is expressed as 
a percentage of the normalized DMSO-treated reporter 
activity.Page 6 of 12
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(A) Effect of protein synthesis inhibition on the downregulation of Nrl and Crx by TSAFigur  5
(A) Effect of protein synthesis inhibition on the downregulation of Nrl and Crx by TSA. P2 retinal explant cultures were 
treated with TSA, TSA plus cycloheximide, or DMSO for 3 hours, followed by Northern blot analysis. (B) Effect of HDAC inhi-
bition on histone acetylation by western blot analysis. (C) Effect of HDAC inhibition on the acetylation of non-histone proteins 
by western blot analysis. The blot was sequentially probed with a pan acetyl-lysine antibodyn (top blot), an acetyl-tubulin anti-
body (middle blot), and an α-tubulin antibody (bottom blot).
BMC Developmental Biology 2007, 7:78 http://www.biomedcentral.com/1471-213X/7/78[27,28,32]. Neurod1 also promotes rod photoreceptor
development, as overexpression of Neurod1 favors the
production of rods at the expense of bipolar cells and
Müller glia, and Neurod1 is required for the survival of
rod photoreceptor cells [35]. TSA treatment led to a reduc-
tion in the expression of all of these key regulators of rod
development, and of rod development itself. Downregu-
lation of these regulators took place quickly, within 3
hours, before cell death was observed, 20 hours after TSA
treatment. As there was not a general downregulation of
gene expression observed on the microarrays, and the
effect on the pro rod genes was so rapid, it is unlikely that
the effect of TSA on the expression of these key regulators
resulted from the cell death effect exerted by TSA. In addi-
tion, TSA led to an inhibition of Müller glia development.
This may hold generally true in the central nervous sys-
tem, as inhibition of HDAC activity in multipotent hip-
pocampal neural progenitor cells inhibits glial cell
formation [44]. TSA treatment also led to a reduction in
total cell counts due to reduced cell proliferation and
increased cell apoptosis. However, the observed approxi-
mately 30% reduction in cell numbers does not explain a
3 fold increase in bipolar cells when HDAC activity was
inhibited by TSA in the retinal explant cultures. Taken
together, these results suggest that loss of HDAC activity
can drive the bipolar cell fate at the expense of other fates.
It is interesting to consider this effect in light of the fact
that all proliferation was inhibited by TSA. Birthdating
experiments in the mouse (34) have shown that the vast
majority of bipolar cells are generated postnatally from
mitotic progenitor cells. The observation of additional
bipolar cells following TSA treatment suggests that the
bipolar cells in the TSA-treated cultures resulted from fate
effects on cells that were postmitotic when the cultures
were initiated, and were most likely those cells normally
fated to be rods.
Although the function of the transcription factors control-
ling rod development has been revealed, little is known
regarding the regulation of their expression. The results of
this study demonstrate that HDACs play an important
role in regulating their expression at the initial stages of
rod development. Clearly, HDAC activity is required for
the expression of a panel of pro-rod genes. The mainte-
nance of expression of Nrl and Crx in the mature retina
also requires HDACs, indicating that the function of
HDACs in controlling retinal gene expression extends
beyond the early developmental stage.
HDACs are generally described as transcriptional repres-
sors. Class I HDACs are ubiquitously expressed in the
nucleus. Class II HDACs are capable of shuttling in and
out of the nucleus in response to signals. The association
of Class II HDACs with the transcription factor MEF2
repressed cardiomyocyte differentiation through the
silencing of MEF2-mediated gene transcription. Phospho-
rylation of Class II HDACs (HDAC 4, 5, 7) caused them to
move from the nucleus to the cytoplasm, thus releasing
transcription repression, and allowing myocytes to differ-
entiate. However, recent studies have implicated HDACs
in the process of transcription activation, providing evi-
dence that HDACs can also act as transcription activators,
inducing interferon-stimulated gene expression and the
subsequent antiviral response [21-24]. These new findings
strongly suggest that the relative acetylation level of
HDAC target proteins, regulated by the opposing acitivity
of HDACs and HATs, determines the transcription states
of specific genes, either activating or repressing transcrip-
tion. Our results support a role of HDACs as transcription
HDAC inhibition leads to cell cycle arrest and apoptotic cell deathFigure 6
HDAC inhibition leads to cell cycle arrest and apoptotic cell 
death. P2 mouse retinal explants were cultured in the pres-
ence of 100 nM TSA or DMSO for 20 hours before one hour 
of BrdU labeling, shown in (A), and TUNEL cell death detec-
tion, shown in (B).Page 8 of 12
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activity of Nrl and Crx. However, from the reporter analy-
sis of Nrl and Crx promoters, we can not completely
exclude the possibility that TSA acted indirectly on the Nrl
and Crx promoters via activation of transcription repres-
sors that in turn act on the Nrl and Crx promoters. In the
latter case, a transcription repressor protein would need to
be induced, whose expression is normally repressed by
HDACs. Given the fast action of TSA to nearly abolish the
expression of Nrl and Crx within 3 hours, even in the pres-
ence of a protein synthesis inhibitor cycloheximide, it is
more likely that the HDACs are transcription activators of
these key retinal development regulators.
It is known that HDACs have many non-histone target
proteins. Some are nuclear transcription factors, such as
GATA4, NFAT, RB, and p53; others are cytoplasmic tar-
gets, such as tubulin and hsp90, which were identified as
substrates for HDAC6. HDAC6 deacetylates α-tubulin,
with a resulting increase in cell motility [11]. Recently, it
was found that HDAC6 mediated acetylation controls the
chaperone function of heat shock protein 90 [12,14]. The
biological function of other Class II HDACs, when they
are in the cytoplasm, remains unknown. In our study, TSA
treatment resulted in an increased acetylation of histones
and other cellular proteins, including tubulin and two
other species that are unknown. Interestingly, although
TSA-induced histone acetylation was barely appreciable
after 3 hours, a significantly enhanced acetylation of non-
histone targets was obvious in 3 hours, and the acetyla-
tion levels of these non-histone targets was maintained at
later time points. The fast acetylation of non-histone tar-
gets is consistent with the kinetics of the mRNA downreg-
ulation by TSA. These results suggest that modification of
non-histone targets by HDACs may mediate an important
pathway in the regulation of retinal gene expression.
Using a high-affinity antibody against acetyl-lysine groups
will facilitate the purification and identification of these
non-histone targets of HDACs by mass spectrometry.
Given the multiplicity of family members from the Class
I and Class II HDACs, it is desirable to identify individual
HDACs responsible for their role in gene expression regu-
lation. With the development of inhibitors specific to
individual HDAC family members [45], it should be pos-
sible to address this question in the retina, as well as in
other tissues. In addition, analysis of HDAC knockout
mice will aid in the identification of the functions of indi-
vidual HDACs.
Conclusion
Inhibition of HDACs by the drug, TSA, led to a dramatic
reduction in the differentiation of the most abundant ret-
inal cell type, the rod photoreceptor. Rod differentiation
was completely absent when HDAC activity was blocked.
Key regulators of rod development, the transcription fac-
tors Crx, Nrl, Otx2, and others, were greatly reduced
within 3 hours of the application of the drug. This
appeared to be at least in part due to repression of tran-
scription, as we luciferase assays with the Crx and Nrl reg-
ulatory regions showed that transcription from these
regions was negatively regulated by TSA. No new protein
synthesis was required, suggesting that HDAC activity
might directly positively regulate these promoters. The
cellular outcome of TSA application may indicate a cell
fate switch in that rod photoreceptors and Muller glia
were completely absent from treated cultures, while an
interneuronal cell type, the bipolar cell, was significantly
increased. In addition, cell death was increased, and cell
proliferation was completely blocked by TSA.
Methods
RT-PCR analysis of retinal HDAC expression
Random-primed reverse transcription was carried out
with 2 μg of total RNA isolated from P2 mouse retinal
explants using Superscript II (Invitrogen). The resultant
cDNA was used in a 30-cycle PCR amplification for
Effect of HDAC inhibition on the development of retinal cell typesFigure 7
Effect of HDAC inhibition on the development of retinal cell 
types. P2 mouse retinal explants were cultured in the pres-
ence of 100 nM TSA or DMSO. After 8 days in culture, cells 
were dissociated and immunostained with cell type-specific 
antibodies. Marker positive cells were counted for each anti-
body from 3 independent experiments. Eight hundred to 
1000 cells were counted for each antibody in each experi-
ment. In all of the three experiments, not a single cell was 
detected as Rhodopsin or GS positive when retinal explants 
were treated with TSA. Significance analysis was performed 
using a Student's t-Test. *** p < 0.05. (BP-bipolar cells, Prog-
progenitor cells, RBP-rod bipolar cells, AC-amacrine cells, 
HC-horizontal cells, GC-ganglion cells, MG- Müller glial 
cells.)Page 9 of 12
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GACTCAG-3') and reverse primer (5'-GGCCAACTTGAC-
CTCTTCTTTG-3'), HDAC3 with forward primer (5'-
ATGGCCAAGACCGTGGCGTAT-3') and reverse primer
(5'-ACTTTCCTTGTCGTTGTCATG-3'), HDAC4 with for-
ward primer (5'-AAGAAGCTTGTGGCAACTTG-3') and
reverse primer (5'-TGAGTTGAGTGGTTTACACG-3'),
HDAC5 with forward primer (5'-CAAACACTGGAGCT-
GTGTAC-3') and reverse primer (5'-TCCATGGGCTC-
CTCTGCTGG-3'), and HDAC6 with forward primer (5'-
TTTCCCTTCTGAGGCCACAG-3') and reverse primer (5'-
TCCTTCTGGGTAGAACAGAG-3'). PCR products were
cloned into PCR2.1 vector (Invitrogen), and sequenced
using M13 forward primer.
Northern blot analysis
Approximately 10 μg of total RNA was isolated with Trizol
(Invitrogen) from retinal explant cultures treated with
either 1 μM TSA (Upstate Cell Signaling Solutions), or 20
μg/ml cycloheximide (Sigma), or DMSO for vehicle-treat-
ment control. Northern blot analysis was performed as
previously described [42].
Microarray analysis
Retinal explants were cultured on filters as previously
described [46]. Cultured explants were treated with either
1 μM TSA or DMSO for 3 hours. Total RNA was extracted
with Trizol (Invitrogen). Approximately 10 μg of total
RNA was used in reverse transcription reaction (Super-
script II from Invitrogen) to label cDNA by incorporating
Cy3- or Cy5-dCTP (Amersham Pharmacia). Cy3- and
Cy5- labeled probes were combined together and hybrid-
ized to a cDNA microarray, consisting of 11,136 clones
from the Brain Molecular Anatomy Project clone set pro-
vided by Dr. Bento Soares (University of Iowa) and over
600 retinal cDNA clones collected in our laboratory [47]
and printed by Biogen (Service kindly provided by Jeff
Shearstone and Steve Perrin). After an overnight hybridi-
zation at 42°C, microarray chips were washed in
0.2XSSC/0.1%SDS at room temperature, followed by two
room temperature washes in 0.2XSSC. Hybridized chips
were scanned with an Axon GenePix scanner (Axon
Instruments) and acquired images were analyzed using
the GenePix software package (Axon Instruments).
Luciferase reporter assay by in vitro electroporation
7 kb Nrl (NCBI: NT_039606, 28897897–28904977, Mat-
suda and Cepko, [48]) and 5 kb Crx (NCBI: NT_109951,
13369–18369, Matsuda and Cepko, [48]) promoter
sequences were cloned into firefly luciferase plasmid
pGL3-basic (Promega). Promoter luciferase reporter con-
structs were co-transfected with pCAG-renilla luciferase
plasmid into P2 mouse retinae using an in vitro electropo-
ration technique [49]. In short, 1.0 μg/μl of promoter fire-
fly luciferase and 0.5 μg/μl pCAG-renilla luciferase
plasmids were prepared in PBS and placed into a microe-
lectroporation chamber (Nepagene, model CUY532) that
contained dissected mouse retinae. Unidirectional electric
pulses were applied at 50 milliseconds 5 times, each of
which was followed by a 950 milliseconds pause. Electro-
porated retinae were recovered in an overnight culture
before being treated with either 1 μM TSA or DMSO for 24
hours. Retinal lysates were prepared and used for a dual
luciferase assay following the instructions from the man-
ufacturer (Promega).
Western blot analysis
P2 mouse retinal explants were cultured in the presence of
1 μM TSA for 3 and 24 hours. Protein lysates were
extracted with 1% TritonX-100 TBS containing 20 mM
Tris-Cl, pH 7.4, 150 mM NaCl, 1 mM EDTA, and cocktail
protease inhibitor mix (Roche). Extracted proteins were
resolved on 4–20% Tris-glycine SDS PAGE and transferred
to nitrocellulose membrane followed by immunoblot
with antibodies against actyl-lysine (Cell Signaling Tech-
nology), actyl-tubulin (Sigma), and α-tubulin (Sigma).
Bound primary antibodies were visualized by HRP-conju-
gated secondary antibody and Supersignal Detection
Methods (Pierce).
TUNEL assay
P2 mouse retinal explants were treated with 100 nM TSA
or DMSO for 20 hours, fixed with 4% paraformaldehyde
in PBS, pH 7.4, and equilibrated in 30% sucrose in PBS.
Cryosections were permeabilized with 0.1% Triton X-100
in 0.1% sodium citrate for 2 minutes on ice before incu-
bation with TUNEL reaction mixture (Roche) for 1 hour at
37°C. DAPI counterstained sections were washed 3 times
with PBS and analyzed by fluorescence microscopy.
BrdU labeling and detection
P2 mouse retinal explants were treated with 100 nM TSA
or DMSO for 20 hours, and then were labeled by 10 μM
BrdU (Roche) in culture medium for 1 hour at 37°C. Ret-
inal explants were fixed in 4% paraformaldehyde and
equilibrated in 30% sucrose in PBS. Cryosections were
treated with 4N HCl for 10 minutes and washed three
times with PBS. BrdU positive cells were detected by anti-
BrdU immunostaining (Roche) and fluorescence micros-
copy.
Dissociated cell immunofluorescence
P2 mouse retinal explants were cultured in the presence of
either 100 nM TSA or DMSO. After 8 days in culture, reti-
nal explants were collected and washed in PBS. Cleaned
explants were dissociated with Papain (Worthington Bio-
chemical Corporation) according to manufacturer's
instructions. Dissociated cells were fixed onto glass slides
and stained with antibodies against: Rhodopsin, Rho4D2
(mouse monoclonal from Dr. R. Molday [50], 1:200),Page 10 of 12
(page number not for citation purposes)
BMC Developmental Biology 2007, 7:78 http://www.biomedcentral.com/1471-213X/7/78Chx10 (rabbit polyclonal from our lab, 1:500), PKCα
(mouse monoclonal from Oncogene, 1:100), Pax6
(mouse monoclonal from University of Iowa Develop-
mental Studies Hybridoma Bank, 1:500), GS (mouse
monoclonal from Chemicon, 1:500), CyclinD3 (rabbit
polyclonal from Santa Cruz, 1:200), and ApoE (goat pol-
yclonal from Santa Cruz, 1:100). After several washes with
PBS, positively-stained cells were identified by corre-
sponding Cy3-conjugated secondary antibodies (Jackson
Immunoresearch Laboratory). Cells were counterstained
with DAPI and visualized with Nikon Eclipse E1000
microscope.
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